© 2021 MJH Life Sciences and Psychiatric Times. All rights reserved.
© 2021 MJH Life Sciences™ and Psychiatric Times. All rights reserved.
Dr Brannan is chief medical officer at Karuna Therapeutics and a neuroscience drug development expert.
December 23, 2020
Hear details from the phase II trial of xanomeline-trospium and how it assists in the treatment of acute schizophrenia.